Teva settles price-fixing claims in Florida for $6.73M

Teva Pharmaceuticals has reached agreement with the Attorney General of Florida to settle the state’s price-fixing claims against Teva. Under the terms of the settlement, Teva will pay the state $6.73M, and the state will dismiss all of its claims against Teva and its affiliates once payment has been made. Teva is committed to doing business the right way, in compliance with all applicable laws. Consistent with that commitment, Teva has also agreed, as part of its settlement with Florida, to maintain its antitrust training and compliance efforts throughout the United States. This is the fifth settlement of price-fixing claims that Teva has reached to date. Each settlement, including this settlement with Florida, has followed the same framework, with Teva agreeing to pay each state an amount proportional to its share of the national population. And Teva’s $6.73M payment to Florida falls within the estimated provision that Teva’s management recorded in the third quarter of 2022, related to this litigation.